'We strongly dissent': Women biotech execs pen letter to colleagues and politicians in Roe v. Wade aftermath
In the days following the US Supreme Court’s rollback of federal abortion rights, more than 100 women biotech executives came together in an open letter to condemn the ruling and tell their fellow drug development leaders that they “will not stand by silently.”
Addressed to industry, friends, legislators and elected officials, the biotech executives said they were joining “the resounding millions in chorus” by showing their “profound dismay and disappointment” at the decision handed down by SCOTUS last week, a reversal of Roe v. Wade that had been anticipated for weeks following a court leak.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.